These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 38717725)

  • 1. Isolated Perfused Hearts for Cardiovascular Research: An Old Dog with New Tricks.
    Yang T; Liu Z; Shu S; Chen Z; Hua X; Song J
    J Cardiovasc Transl Res; 2024 May; ():. PubMed ID: 38717725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normothermic
    Lu J; Xu L; Zeng Z; Xue C; Li J; Chen X; Zhou P; Lin S; Liao Y; Du X; Yang R; Zheng S
    Front Cell Dev Biol; 2021; 9():733183. PubMed ID: 34532321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cardioprotective preservation strategy employing ex vivo heart perfusion facilitates successful transplant of donor hearts after cardiocirculatory death.
    White CW; Ali A; Hasanally D; Xiang B; Li Y; Mundt P; Lytwyn M; Colah S; Klein J; Ravandi A; Arora RC; Lee TW; Hryshko L; Large S; Tian G; Freed DH
    J Heart Lung Transplant; 2013 Jul; 32(7):734-43. PubMed ID: 23796155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Rodent Model of Cardiac Donation After Circulatory Death and Novel Biomarkers of Cardiac Viability During Ex Vivo Heart Perfusion.
    Kearns MJ; Miller SD; Cheung A; Bashir J; Wong S; Seidman MA; Boyd JH
    Transplantation; 2017 Aug; 101(8):e231-e239. PubMed ID: 28505025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo perfusion of the donor heart: Preliminary experience in high-risk transplantations.
    Dang Van S; Gaillard M; Laverdure F; Thes J; Venhard JC; Fradi M; Vallée A; Ramadan R; Hébert G; Tamarat R; Deleuze P; Guihaire J
    Arch Cardiovasc Dis; 2021 Nov; 114(11):715-726. PubMed ID: 34620574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial Functional Decline During Prolonged Ex Situ Heart Perfusion.
    Hatami S; White CW; Shan S; Haromy A; Qi X; Ondrus M; Kinnear A; Himmat S; Michelakis E; Nagendran J; Freed DH
    Ann Thorac Surg; 2019 Aug; 108(2):499-507. PubMed ID: 30872100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of donor heart viability during ex vivo heart perfusion.
    White CW; Ambrose E; Müller A; Li Y; Le H; Hiebert B; Arora R; Lee TW; Dixon I; Tian G; Nagendran J; Hryshko L; Freed D
    Can J Physiol Pharmacol; 2015 Oct; 93(10):893-901. PubMed ID: 26317524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of natural IgM in the hyperacute rejection of discordant heart xenografts.
    Gambiez L; Salame E; Chereau C; Calmus Y; Cardoso J; Ayani E; Houssin D; Weill B
    Transplantation; 1992 Oct; 54(4):577-83. PubMed ID: 1412747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-ischemic Heart Preservation via Hypothermic Cardioplegic Perfusion Induces Immunodepletion of Donor Hearts Resulting in Diminished Graft Infiltration Following Transplantation.
    Critchley WR; Stone JP; Liao Q; Qin G; Risnes I; Trafford A; Scott H; Sjöberg T; Steen S; Fildes JE
    Front Immunol; 2020; 11():1621. PubMed ID: 32849549
    [No Abstract]   [Full Text] [Related]  

  • 10. Chimeric pig hearts resist hyperacute rejection in ex vivo perfusion model.
    Yang T; Stammers A; Jiang J; Shearon C; Thompson S; Beschorner WE
    J Extra Corpor Technol; 2001 Sep; 33(3):181-4. PubMed ID: 11680732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroids Limit Myocardial Edema During Ex Vivo Perfusion of Hearts Donated After Circulatory Death.
    Sandha JK; White CW; Müller A; Avery E; Thliveris J; Dixon IMC; Arora RC; Tian G; Hryshko LV; Nagendran J; Freed DH
    Ann Thorac Surg; 2018 Jun; 105(6):1763-1770. PubMed ID: 29382512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A whole blood-based perfusate provides superior preservation of myocardial function during ex vivo heart perfusion.
    White CW; Hasanally D; Mundt P; Li Y; Xiang B; Klein J; Müller A; Ambrose E; Ravandi A; Arora RC; Lee TW; Hryshko LV; Large S; Tian G; Freed DH
    J Heart Lung Transplant; 2015 Jan; 34(1):113-121. PubMed ID: 25447577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel portable hypothermic machine perfusion preservation device enhances cardiac viability of donated human hearts.
    Andrijauskaite K; Veraza RJ; Lopez RP; Maxwell Z; Cano I; Cisneros EE; Jessop IJ; Basurto M; Lamberson G; Watt MD; Nespral J; Ono M; Bunegin L
    Front Cardiovasc Med; 2024; 11():1376101. PubMed ID: 38628313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-level endothelial expression of human CD59 prolongs heart function in an ex vivo model of xenograft rejection.
    Cowan PJ; Somerville CA; Shinkel TA; Katerelos M; Aminian A; Romanella M; Tange MJ; Pearse MJ; d'Apice AJ
    Transplantation; 1998 Mar; 65(6):826-31. PubMed ID: 9539095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-four-hour normothermic perfusion of isolated ex vivo hearts using plasma exchange.
    Tchouta L; Drake D; Hoenerhoff M; Rojas-Pena A; Haft J; Owens G; Bartlett R;
    J Thorac Cardiovasc Surg; 2022 Jul; 164(1):128-138. PubMed ID: 33485659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of human anti-porcine "natural antibodies" recovered from ex vivo perfused hearts--predominance of IgM and IgG2.
    Ross JR; Kirk AD; Ibrahim SE; Howell DN; Baldwin WM; Sanfilippo FP
    Transplantation; 1993 May; 55(5):1144-50. PubMed ID: 8497896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normothermic
    Xu L; Zeng Z; Niu C; Liu D; Lin S; Liu X; Szabó G; Lu J; Zheng S; Zhou P
    Front Cardiovasc Med; 2023; 10():1126391. PubMed ID: 37008319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex Vivo Heart Perfusion for 72 Hours Using Plasma Cross Circulation.
    McLeod JS; Poling C; Church JT; Jung J; Sarosi E; Langley M; Hayes M; Phillips JP; Hirschl J; Weir W; Hoenerhoff M; Rojas-Pena A; Bartlett RH; Owens GE
    ASAIO J; 2020 Jul; 66(7):753-759. PubMed ID: 31453833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of ischemic time on hyperacute xenograft rejection of pig hearts in a working heart perfusion model with human blood.
    Brenner P; Hinz M; Huber H; Schmoeckel M; Reichenspurner H; Meiser B; Hammer C; Reichart B
    Transpl Int; 2000; 13 Suppl 1():S494-503. PubMed ID: 11112061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Custodiol vs warm blood cardioplegia and conditioning of donor hearts during transportation with the organ care system.
    Kaliyev R; Lesbekov T; Bekbossynov S; Bekbossynova M; Nurmykhametova Z; Novikova S; Smagulov N; Medressova A; Faizov L; Ashyrov Z; la Fleur P; Samalavicius R; Pya Y
    J Card Surg; 2019 Oct; 34(10):969-975. PubMed ID: 31332833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.